Overview

Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this research study is to find out how Avenova (0.01 % hypochlorous acid) works compared to Betadine (Povidone iodide) for reducing bacteria and patient discomfort in the eyes.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Miami
Treatments:
Povidone
Povidone-Iodine
Criteria
Inclusion criteria:

Treatment Naïve patients:

- Any patient who is able to give consent for the study and did not receive an intravitreal
injection in the past 6 months

Patients receiving injections:

- Patient currently undergoing treatment for which he/she receives a intravitreal injection
in one eye.

Exclusion Criteria:

Treatment Naïve patients:

- Intravitreal injections in the past 6 months

- Use of eye drops for treatment of glaucoma in the past 6 months

- Use of eye drops with antibiotics or steroids in the past 6 months

Patients receiving injections:

- Patient receiving injections in both eyes

- Use of eye drops for treatment of glaucoma in the past 6 months

- Use of eye drops with antibiotics or steroids in the past 6 months

- Have any condition that, in the opinion of the investigator, would compromise the
well-being of the patient or the study or prevent the patient from meeting or
performing study requirements.

For both groups:

- Adults unable to consent

- Individuals who are not yet adults (infants, children, teenagers)

- Pregnant women

- Prisoners